[go: up one dir, main page]

GB984517A - New derivatives of 5-amino-isoindoline - Google Patents

New derivatives of 5-amino-isoindoline

Info

Publication number
GB984517A
GB984517A GB19368/63A GB1936863A GB984517A GB 984517 A GB984517 A GB 984517A GB 19368/63 A GB19368/63 A GB 19368/63A GB 1936863 A GB1936863 A GB 1936863A GB 984517 A GB984517 A GB 984517A
Authority
GB
United Kingdom
Prior art keywords
group
cor111
amino
hydrogen atom
isoindoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB19368/63A
Inventor
Andreas Schuhmann
Bernd Fritzsche
Joachim Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva GmbH
Original Assignee
Arzneimittelwerk Dresden GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE634851D priority Critical patent/BE634851A/xx
Application filed by Arzneimittelwerk Dresden GmbH filed Critical Arzneimittelwerk Dresden GmbH
Priority to GB19368/63A priority patent/GB984517A/en
Publication of GB984517A publication Critical patent/GB984517A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises 5-amino isoindolines of the general formula <FORM:0984517/C2/1> wherein R1 is a hydrogen atom and R11 is a COR111 group, R111 being a hydrogen atom or an aliphatic, araliphatic, aromatic, or heterocyclic radical; or R1 is a COR111 group and R11 is a hydrogen atom a COR111 group or an aliphatic radical; salts thereof with physiologically acceptable acids and the preparation of such compounds when R is a hydrogen atom and R11 is a COR11 group, by acylating 5 -nitro-isoindoline and reducing the aromatic nitro group; when R1 is a COR111 group and R11 is a hydrogen atom, by providing the heterocyclic nitrogen atom with a protective grouping, acylating the 5-amino group and then removing the protective group; when R1 is COR111 and R11 is an aliphatic radical, by acylating a 5-amino isoindoline bearing an aliphatic radical in the 2-position; and when both R1 and R11 are both COR111 radicals, by acylating 5-amino-isoindoline.ALSO:Pharmaceutical compositions having analgesic, antipyretic and antiphlogistic properties comprise compounds of the formula <FORM:0984517/A5-A6/1> and their salts with physiologically acceptable acids, either alone or in admixture with known analgesic, antipyretic and/or antiphlogistic compounds (whereby such mixtures can also exhibit synergism). The compositions may be in the form of solutions for parenteral or dropwise administration, tablets or dragees.
GB19368/63A 1963-05-15 1963-05-15 New derivatives of 5-amino-isoindoline Expired GB984517A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BE634851D BE634851A (en) 1963-05-15
GB19368/63A GB984517A (en) 1963-05-15 1963-05-15 New derivatives of 5-amino-isoindoline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB19368/63A GB984517A (en) 1963-05-15 1963-05-15 New derivatives of 5-amino-isoindoline

Publications (1)

Publication Number Publication Date
GB984517A true GB984517A (en) 1965-02-24

Family

ID=10128179

Family Applications (1)

Application Number Title Priority Date Filing Date
GB19368/63A Expired GB984517A (en) 1963-05-15 1963-05-15 New derivatives of 5-amino-isoindoline

Country Status (2)

Country Link
BE (1) BE634851A (en)
GB (1) GB984517A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014792A1 (en) * 1979-01-22 1980-09-03 Eli Lilly And Company Tetrahydro-2H-benzo(c)pyrroles, their preparation, pharmaceutical compositions containing them and the compounds for use as therapeuticals
WO1997048683A1 (en) * 1996-06-17 1997-12-24 Smithkline Beecham Plc Substituted benzamide derivatives and their use as anticonvulsants
WO2002014277A1 (en) * 2000-08-10 2002-02-21 Tanabe Seiyaku Co., Ltd. Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof
WO2002014276A1 (en) * 2000-08-10 2002-02-21 Tanabe Seiyaku Co., Ltd. Benzoylaminoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof
WO2008038053A1 (en) * 2006-09-29 2008-04-03 Lectus Therapeutics Limited Ion channel modulators & uses thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014792A1 (en) * 1979-01-22 1980-09-03 Eli Lilly And Company Tetrahydro-2H-benzo(c)pyrroles, their preparation, pharmaceutical compositions containing them and the compounds for use as therapeuticals
DK155600B (en) * 1979-01-22 1989-04-24 Lilly Co Eli ANALOGUE PROCEDURE FOR THE PREPARATION OF TETRAHYDRO-2H-BENZO (C) PYRROLES AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF AND THE INTERMEDIATE USE OF THE PROCEDURE
WO1997048683A1 (en) * 1996-06-17 1997-12-24 Smithkline Beecham Plc Substituted benzamide derivatives and their use as anticonvulsants
US6110934A (en) * 1996-06-17 2000-08-29 Smithkline Beecham P.L.C. Substituted benzamide derivatives and their use as anticonvulsants
WO2002014277A1 (en) * 2000-08-10 2002-02-21 Tanabe Seiyaku Co., Ltd. Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof
WO2002014276A1 (en) * 2000-08-10 2002-02-21 Tanabe Seiyaku Co., Ltd. Benzoylaminoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof
WO2008038053A1 (en) * 2006-09-29 2008-04-03 Lectus Therapeutics Limited Ion channel modulators & uses thereof
WO2008038051A3 (en) * 2006-09-29 2008-06-19 Lectus Therapeutics Ltd Use of ion channel modulators in the prophylaxis and treatment of inflammatory and immunological diseases

Also Published As

Publication number Publication date
BE634851A (en) 1900-01-01

Similar Documents

Publication Publication Date Title
ES2081120T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF BACATINE III AND DESACETIL-10 BACATINE III.
AU2001272666A1 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
GB984517A (en) New derivatives of 5-amino-isoindoline
ES399808A1 (en) N-acyl biscarbamate herbicides
JPS5283380A (en) Synthesis of thiocarbostyril derivatives
ES392093A1 (en) 2-amino-5-chloro-thiazole derivatives
NO922151L (en) GINGEROL AND GINGERDIOLD DERIVATIVES AS HYPOCOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS
ES430676A1 (en) 2-Substituted -1,2,4-thiadiazolo-(2,3-a)benzimidazoles and process for their preparation
ES435413A1 (en) (Trifluoromet hylphenoxy)-phenylurea compounds and herbicidal compositions
ES381691A1 (en) Procedure to influence the growth of higher plants. (Machine-translation by Google Translate, not legally binding)
JPS5266626A (en) Non-medical fungicide and anti-phytophagineae agent, and their prepara tion
ES346350A1 (en) Benzothiopyrone compounds
JPS54129132A (en) Remedy and prophylactic for prostatomegaly
ES456048A1 (en) Pyridoxine derivatives
GB992222A (en) Hypoglycemic compositions containing acyl disulphides and their esters
ES442547A1 (en) Heterocyclic substituted chromenopyrazoles
ES271763A1 (en) Procedure for the preparation of amino fluorate derivatives (Machine-translation by Google Translate, not legally binding)
ES294368A1 (en) Procedure for the preparation of nitro coloring pigments (Machine-translation by Google Translate, not legally binding)
GB1388638A (en) Compositions containing n-alkyl or n,n-dialkyl-2,2-bis rho-chlorophenoxy acetamides
FR1541415A (en) Biocidal compositions containing 1, 2, 3, -thiadiazole, novel 1, 2, 3-thiadiazole derivatives, and their preparation
ES370226A1 (en) Cycloheptimidazolone derivatives and process for the preparation thereof
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS52148076A (en) Preparations of oxathiazole derivatives
DE69215900D1 (en) Cyclopropyl-n-hydroxyharnstoff als lypoxygenaseinhibitoren
GB1164004A (en) Novel Insecticidal Compositions